Current Allergy and Asthma Reports

SJR Rank #2,126H-index: 89SJR: 1.609Best quartile: Q1APC: US$4,590
Journal website: aims, scope and author guidelines
Publisher

Springer

Country

United States

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • ImmunologyQ1
  • Immunology and AllergyQ1
  • Pulmonary and Respiratory MedicineQ1

Areas: Immunology and Microbiology · Medicine

Most published research topics

Asthma and respiratory diseasesAllergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchSinusitis and nasal conditionsContact Dermatitis and AllergiesRespiratory and Cough-Related ResearchDermatology and Skin DiseasesDrug-Induced Adverse ReactionsEosinophilic EsophagitisMast cells and histamine

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04080120160

Documents per Year

20222025020406080

Detailed Information

ISSN

1529-7322, 1534-6315

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

6.62

References per Document

96.16

Coverage

2001-2026

Scope

The aim of this journal is to systematically provide the views of highly selected experts on current advances in the fields of allergy and asthma and highlight the most important papers recently published. All reviews are intended to facilitate the understanding of new advances in science for better diagnosis, treatment, and prevention of allergy and asthma. We accomplish this aim by appointing international experts in major subject areas across the discipline to review select topics emphasizing recent developments and highlighting important new papers and emerging concepts. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. Over a one- to two-year period, readers are updated on all the major advances in allergy and asthma.

Metrics from SCImago Journal Rank 2025. View on SCImago